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Pterygium is a disfiguring disease that can
potentially lead to blindness; complex surgery
may be required to restore vision in advanced
stages (Solomon et al. 2001). In general, ptery-
gium is more prevalent in tropical and sub-
tropical areas, where the residents have high
levels of sunlight exposure (Nakaishi et al.
1997). In previous studies on general popula-
tions, the prevalence of pterygium was 17% in
residents on a tropical island in Indonesia (Tan
et al. 2006) and as high as 31.06% in Lima,
Peru (Rojas and Malaga 1986). Because sun-
light is a major risk factor, differences in sun-
light exposure may lead to very different risks
in people living in the same area. For example,
two groups of residents of the Brazilian
Amazonian rain forest with different lifestyles
had prevalence rates of 36.6% and 5.0%,
respectively (Paula et al. 2006). Nonetheless,
even in developed countries, high prevalence
rates of pterygium can still be observed. A
study in Singapore found the prevalence was
6.9% among Chinese persons ≥ 40 years of
age (Wong et al. 2001), and a study in
Australia found a prevalence of 7.3% among
men > 49 years of age (McCarty et al. 2000).
Pterygium is a winglike fibrovascular
growth of the bulbar conjunctiva and under-
lying subconjunctival tissue of the inter-
palpebral ﬁssure that may encroach onto the
cornea (Jaros and DeLuise 1988). The mecha-
nism of pterygium formation is not yet fully
understood. Recent data have provided evi-
dence implicating genetic components, anti-
apoptotic mechanisms, cytokines, growth
factors, extracellular matrix remodeling
(through the actions of matrix metallo-
proteinase), immunologic mechanisms, and
viral infections in the pathogenesis of this dis-
ease (Chen et al. 1994; Kwok et al. 1994).
Ultraviolet light has long been recognized as a
major risk factor for pterygium (McCarty
et al. 2000; Moran and Hollows 1984; Wong
et al. 2001); in addition to sunlight, ultra-
violet radiation from welding may also cause
the disease (Karai and Horiguchi 1984). Some
other environmental risk factors have also
been identiﬁed, including dust, low humidity,
microtrauma secondary to smoke or sand, and
human papilloma virus infection (Taylor et al.
1989; Varinli et al. 1994). Furthermore,
pterygium has some tumorlike features, such
as abnormal p53 expression and uncontrolled
cell proliferation (Shimmura et al. 2000;
Weinstein et al. 2002).
Arsenic, a ubiquitous element in the crust
of the earth, may promote cell proliferation
and is known to cause both malignant and
benign tumors in human beings (Lau et al.
2004; Luster and Simeonova 2004; U.S.
Environmental Protection Agency 2001). It is
transported in the environment mainly by
water and can be found in organic and inor-
ganic forms in soil, air, water, and food.
Humans can be exposed to arsenic from the
natural environment, industrial pollution,
medications, and food. Long-term exposure
to ingested arsenic through drinking well
water has been documented for > 50 years in
an area in the southwestern coastal region of
Taiwan, which is generally known as the
blackfoot disease (BFD)-endemic area (BFD
area) because of the prevalence of BFD, a
peripheral vascular disease that may cause
gangrene and thus lead to black discoloration
of the affected foot (Ch’i and Blackwell
1968; Tseng 1977, 1989). It is generally
believed that arsenic in drinking water is the
cause of this disease. Associations have also
been observed between arsenic exposure and
various diseases, including cancers and other
vascular diseases (Chen et al. 1985; Chiou
et al. 1997, 2005; Guo 2004; Guo et al.
1997, 2001, 2004; Ibrahim et al. 2006;
Wang et al. 2003; Wu et al. 1989). To evalu-
ate the association between arsenic exposure
and the development of pterygium, we con-
ducted a study in the southwestern coastal
region of Taiwan.
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BACKGROUND: Pterygium is a fibrovascular growth of the bulbar conjunctiva and underlying
subconjunctival tissue that may cause blindness. The mechanism of pterygium formation is not yet
fully understood, but pterygium has some tumorlike features.
OBJECTIVES: The objective of this study was to evaluate the association between arsenic exposure
through drinking water and the occurrence of pterygium in southwestern Taiwan.
METHODS: We recruited participants > 40 years of age from three villages in the arseniasis-endemic
area in southwestern Taiwan (exposure villages) and four neighboring nonendemic villages (com-
parison villages). Each participant received an eye examination and a questionnaire interview.
Photographs taken of both eyes were later graded by an ophthalmologist to determine pterygium
status. 
RESULTS: We included 223 participants from the exposure villages and 160 from the comparison
villages. The prevalence of pterygium was higher in the exposure villages across all age groups in
both sexes and increased with cumulative arsenic exposure. We found a significant association
between cumulative arsenic exposure and the prevalence of pterygium. After adjusting for age, sex,
working under sunlight, and working in sandy environments, we found that cumulative arsenic
exposure of 0.1–15.0 mg/L-year and ≥ 15.1 mg/L-year were associated with increased risks of
developing pterygium. The adjusted odds ratios were 2.04 [95% confidence interval (CI),
1.04–3.99] and 2.88 (95% CI, 1.42–5.83), respectively. 
CONCLUSIONS: Chronic exposure to arsenic in drinking water was related to the occurrence of
pterygium, and the association was still observed after adjusting for exposures to sunlight and sandy
environments.
KEY WORDS: arsenic, prevalence, pterygium, ultraviolet radiation, water pollutant. Environ Health
Perspect 116:952–955 (2008). doi:10.1289/ehp.11111 available via http://dx.doi.org/ [Online
9 April 2008]Materials and Methods
We recruited participants from residents older
than 40 years of age from the BFD area and a
neighboring township without high arsenic
levels in drinking water. Because water from
shallow wells in the BFD area has high salin-
ity, residents started consuming water from
artesian wells nearly a century ago. Before the
implementation of the tap water supply system
in the 1960s, water from artesian wells was
used for drinking and cooking. We selected the
three villages with the highest prevalence of
BFD as exposure villages, including Homei
(prevalence of BFD: 13.6 cases/1,000), Fuhsin
(9.6/1,000), and Hsinming (10.3/1,000), all
in Putai Township, Chiayi County. High
arsenic levels were found in the water from
artesian wells in the BFD area, with the
median arsenic concentration ranging from
0.70 to 0.93 mg/L in Putai Township (Chen
et al. 1962). In addition, we included four vil-
lages with latitudes similar to that of Putai
Township (N23.0°–N23.5°) as comparison
villages, including Xinghua, Dongning,
Liu’an, and Jiannan, all in Jiali Township,
Tainan County (Wu et al. 1961). The median
arsenic concentrations of well water in these
villages were < 0.005 mg/L (Lo et al. 1977).
Residents of these two groups of villages have
similar racial origins, socioeconomic status,
living environment, lifestyles, dietary patterns,
medical facilities, and educational levels.
The recruitment procedure from residents
in the exposure villages was described in detail
in a previous report (Lai et al. 1994). The
cumulative arsenic exposure of each partici-
pant was calculated as the sum of products,
derived by multiplying the arsenic concentra-
tion in well water by the duration of water
consumption during consecutive periods of
living in different villages. The cumulative
arsenic exposure was classiﬁed as unknown if
the arsenic concentration of well water in any
village where the participant had lived was
unavailable. Only those who had lived in the
same group of villages for > 5 years were
recruited. We invited 430 residents in the
exposure villages and 303 residents in the com-
parison villages to attend the health survey; the
two groups of participants were frequency
matched for age and sex.
Each participant received an eye examina-
tion conducted by an ophthalmologist and
was given a questionnaire interview in 2005.
The eye examination included measurement
of the best corrected visual acuity and inspec-
tion of the anterior segment, using a slit lamp.
After the eye examination, a well-trained tech-
nician took four photographs of both eyes
from four different positions: right nasal side,
right temporal side, left nasal side, and left
temporal side. A well-trained interviewer con-
ducted all the personal interviews using a
standard-structure questionnaire to collect data
on demographic characteristics, lifestyle factors
(including alcohol drinking, cigarette smoking,
and betel nut chewing), past medical history,
duration of working under sunlight, and his-
tory of working in sandy environments. 
An ophthalmologist who was blind to the
arsenic exposure status of the participants made
the diagnosis and graded pterygium using the
photographs taken in the field. We adopted
the three-level morphologic classiﬁcation based
on the visibility of the underlying episcleral
blood vessels (Tan et al. 1997a), which is a use-
ful marker of severity (Gazzard et al. 2002). In
grade 1 (atrophic), episcleral vessels are clearly
visible; for grade 2 (intermediate), vessels are
partially visible; and in grade 3 (ﬂeshy), vessels
are wholly obscured. We deﬁned a participant
as positive for pterygium if any pterygium
lesion was observed or a previous history of
surgery for pterygium was conﬁrmed for either
eye. Participants with unclear photographs that
led to uncertainties in the diagnosis were
excluded from further data analyses.
We evaluated differences in categorical
variables between groups using the chi-square
test and difference in continuous variables
using the two-sample t-test. To identify risk
factors for pterygium, we applied univariate
logistic regressions followed by multivariate
logistic regressions. All data analyses were per-
formed using SAS, version 8.0 (SAS Institute
Inc., Cary, NC, USA) or SPSS, version 12.0
(SPSS Inc., Chicago, IL, USA), and all statis-
tical tests were performed at the two-tailed
significance level of 0.05. This study was
approved by the Human Subject Review
Board of the National Health Research
Institutes of Taiwan, and all participants gave
written informed consent prior to the study.
Results
Our study included 223 participants from the
exposure villages and 160 from the comparison
villages. Among candidates from exposure
villages, the mean age (63.3 vs. 64.6 years;
p = 0.17) and the proportion of males (43.2%
vs. 41.8%; p = 0.76) were similar between those
who were included in the further analyses and
who were not. In candidates from the compari-
son villages who were included in the analysis,
the mean age was similar to that of those who
were not included (62.7 vs. 62.1 years;
p = 0.62), but this group had a higher propor-
tion of males (46.0% vs. 30.7%; p = 0.01).
Among the participants included in further
analyses, those who lived in the exposure villages
had age and sex distributions similar to those
who lived in the comparison villages (Table 1).
Of the participants included in the analysis,
134 were found to be positive for pterygium
during the examination, including 126 with
nasal lesions and 34 with temporal lesions.
Because a substantial number of them had a
previous history of surgery for pterygium or
more than one lesion, and thus could not be
classiﬁed properly by the grading system, and
because the number of pterygium patients was
small in certain groups when broken down by
age or other variables, we did not break down
the patients by the grade in the analyses. The
exposure villages had a higher overall prevalence
of pterygium (Table 1), and the prevalence was
higher across all age groups in both sexes
(Table 2). Participants living in the exposure
villages were also more likely to have worked
under sunlight for ≥ 10 years (Table 1).
After adjusting for age and sex, we found
that the prevalence of pterygium increased
with cumulative arsenic exposures (Table 3).
Although the prevalence of pterygium
increased with the duration of artesian well
water consumption, participants who had
consumed artesian well water for ≥ 30 years
had a risk similar to that of those who had
consumed the water for 20–29 years.
Univariate logistic regressions showed that
age, cumulative arsenic exposure, working
under sunlight for ≥ 10 years, and usually or
Arsenic and pterygium
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Table 1. Comparisons between participants living in the exposure villages and comparison villages.
Exposure villages Comparison villages
Variables No. (%) No. (%) p-Valuea
Age (years) 0.96
40–55 55 (24.7) 41 (25.6)
56–65 70 (31.4) 51 (31.9)
> 65 98 (43.9) 68 (42.5)
Sex  0.41
Male  128 (57.4) 85 (53.1)
Female  95 (42.6) 75 (46.9)
Working under sunlight < 0.01
< 10 years 58 (27.2) 99 (62.3)
≥ 10 years 155 (72.8) 60 (37.7)
Working in sandy environments < 0.02
Never or occasionally  152 (80.4) 142 (89.2)
Usually or always  37 (19.6) 17 (10.8)
Pterygium < 0.01
Positive 102 (45.7) 32 (20.0)
Negative 121 (54.3) 128 (80.0)
aChi-square test.always working in sandy environments were
risk factors for pterygium (Table 4). Using
multivariate logistic regression, we found that
all four factors were independent predictors of
pterygium. After adjustment for age, sex,
working under sunlight, and working in sandy
environments, cumulative arsenic exposure
was associated with the risk of developing
pterygium.
Discussion
In this study, we observed a positive association
between the prevalence of pterygium and
cumulative arsenic exposure, and we observed
strong associations between the development
of pterygium and two other environmental risk
factors, sunlight and sand. Most epidemiology
studies have found that sunlight exposure is the
major risk factor for pterygium (Kwok et al.
1994; Taylor et al. 1989). One study found
that the odds ratios (ORs) associated with
current and previous sunlight exposures were
3.54 and 4.52, respectively (Al-Bdour and Al-
Latayfeh 2004). Although the use of sunglasses
offered some protection (Mackenzie et al.
1992), Al-Bdour and Al-Latayfeh (2004) did
not ﬁnd the effect to be statistically signiﬁcant.
In a study in Australia, Mackenzie et al. (1992)
found the risk of pterygium to be increased
several hundred-fold among participants who
worked mainly on sand, compared with those
who worked indoors, and attributed the risk to
the high surface reﬂectance of ultraviolet light.
We speculate that the local irritation caused by
sand may also contribute to the development
of pterygium.
After adjusting for sunlight and sand expo-
sures, we found arsenic to be an independent
predictor for pterygium. The prevalence we
observed was higher than most previous studies
of general populations living even closer to the
equator (Gazzard et al. 2002; Luthra et al.
2001; Saw and Tan 1999; Wong et al. 2001),
which supports our hypothesis that arsenic in
drinking water is an additional risk factor. The
mechanism of pterygium formation associated
with arsenic exposure is unclear, but some
studies found that As(III) can induce tumors in
animal models (Soucy et al. 2003). Therefore,
we speculate that arsenic might cause ptery-
gium through similar mechanisms, including
cell proliferation and angiogenesis. Some stud-
ies have demonstrated common features shared
by pterygium and neoplasms—such as abnor-
mal proliferation, p53 gene overexpression, and
angiogenesis—which supports the argument
that pterygium is a tumorlike growth disorder
(Chen et al. 1994; Dushku and Reid 1997;
Dushku et al. 2001; Kria et al. 1996; Li et al.
2001; Tan et al. 1997b; Shimmura et al. 2000;
Soucy et al. 2003; Weinstein et al. 2002). The
predominance of nasal lesions observed in our
study is compatible with ﬁndings in previous
studies in Taiwan (Chen and Chuang 1976;
Chen et al. 1964; Lin et al. 2006; Wang et al.
1977) and studies in other countries
(Dolezalová 1977; Payrani et al. 1994).
For some study participants, we did not
have data on arsenic levels in drinking water
for all areas where they had lived; thus, we
lacked information on cumulative arsenic
exposure (the “unknown” group in Table 4).
Nonetheless, the duration of drinking artesian
well water was available for all participants,
and we observed a positive association
between the duration of drinking artesian well
water and pterygium. 
Long-term exposure to ingested arsenic
may increase the risks of developing ischemic
heart disease (Chen et al. 1996), cerebral
infarction (Chiou et al. 1997; Wang et al.
2002), microcirculation abnormality (Chiou
et al. 2005; Wang et al. 2003), diabetes melli-
tus (Tseng et al. 2000), hypertension (Chen
et al. 1995), and various cancers (Cantor
2001; Chen et al. 1985, 1988, 1996; Chiou
et al. 1997; Guo 2004; Guo et al. 1997,
1998, 2001, 2004; Smith et al. 1998; Tseng
et al. 1996, 2000; Tsuda et al. 1995; Wu
et al. 1989). Therefore, some residents of the
exposure villages might not be able to partici-
pate in the study because of illness or death
related to arsenic exposure, which leads to
underestimations of the risks of developing
pterygium. Although this will not affect our
conclusion that arsenic exposure is associated
with pterygium, further studies are needed to
obtain more accurate risk estimates.
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